Artemisinin inhibits inflammatory response via regulating NF-κB and MAPK signaling pathways

References

• Sethi G, Ahn KS, Sandur SK, et al. Indirubin enhances tumor necrosis factor-induced apoptosis through modulation of nuclear factor-kappa B signaling pathway. J Biol Chem 2006;281:23425–23435.
   PubMed Web of Science ®Google Scholar
• Meylan E, Dooley AL, Feldser DM, et al. Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma. Nature 2009;462:104–107.
   PubMed Web of Science ®Google Scholar
• DiDonato J, Mercurio F, Rosette C, et al. Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation. Mol Cell Biol 1996;16:1295–1304.
   PubMed Web of Science ®Google Scholar
• Tu Y. The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine. Nature Med 2011;17:1217–1220.
   PubMed Web of Science ®Google Scholar
• White NJ. Antimalarial drug resistance. J Clin Invest 2004;113:1084–1092.
   PubMed Web of Science ®Google Scholar
• Lai HC, Singh NP, Sasaki T. Development of artemisinin compounds for cancer treatment. Invest New Drugs 2013;31:230–246.
   PubMed Web of Science ®Google Scholar
• Park KH, Yoon YD, Han SB, et al. Artemisinin inhibits lipopolysaccharide-induced interferon-beta production in RAW 264.7 cells: implications on signal transducer and activator of transcription-1 signaling and nitric oxide production. Int Immunopharmacol 2012;14:580–584.
   PubMed Web of Science ®Google Scholar
• Cao Q, Jiang Y, Shi J, et al. Artemisinin inhibits the proliferation, migration, and inflammatory reaction induced by tumor necrosis factor-α in vascular smooth muscle cells through nuclear factor kappa B pathway. J Surg Res 2015;194:667–678.
   PubMed Web of Science ®Google Scholar
• Wang Z, Hu W, Zhang JL, et al. Dihydroartemisinin induces autophagy and inhibits the growth of iron-loaded human myeloid leukemia K562 cells via ROS toxicity. FEBS Open Bio 2012;2:103–112.
   PubMed Web of Science ®Google Scholar
• Aldieri E, Atragene D, Bergandi L, et al. Artemisinin inhibits inducible nitric oxide synthase and nuclear factor NF-kB activation. FEBS Lett 2003;552:141–144.
   PubMed Web of Science ®Google Scholar
• Berasain C, Castillo J, Perugorria MJ, et al. Inflammation and liver cancer: new molecular links. Ann N Y Acad Sci 2009;1155:206–221.
   PubMed Web of Science ®Google Scholar
• Hou J, Wang D, Zhang R, et al. Experimental therapy of hepatoma with artemisinin and its derivatives: in vitro and in vivo activity, chemosensitization, and mechanisms of action. Clin Cancer Res 2008;14:5519–5530.
   PubMed Web of Science ®Google Scholar
• Deng XR, Liu ZX, Liu F, et al. Holotransferrin enhances selective anticancer activity of artemisinin against human hepatocellular carcinoma cells. Yi xue Ying De wen ban 2013;33:862–865.
   Google Scholar
• Weifeng T, Feng S, Xiangji L, et al. Artemisinin inhibits in vitro and in vivo invasion and metastasis of human hepatocellular carcinoma cells. Phytomedicine 2011;18:158–162.
   PubMed Web of Science ®Google Scholar
• Sanchez-Fidalgo S, da Silva MS, Cardeno A, et al. Abarema cochliacarpos reduces LPS-induced inflammatory response in murine peritoneal macrophages regulating ROS-MAPK signal pathway. J Ethnopharmacol 2013;149:140–147.
   PubMed Web of Science ®Google Scholar
• Jin HR, Jin SZ, Cai XF, et al. Cryptopleurine targets NF-kappaB pathway, leading to inhibition of gene products associated with cell survival, proliferation, invasion, and angiogenesis. PLoS One 2012;7:e40355.
   PubMed Web of Science ®Google Scholar
• Jin X, Jin HR, Jung HS, et al. An atypical E3 ligase zinc finger protein 91 stabilizes and activates NF-kappaB-inducing kinase via Lys63-linked ubiquitination. J Biol Chem 2010;285:30539–30547.
   PubMed Web of Science ®Google Scholar
• Wu X, Song M, Rakariyatham K, et al. Inhibitory effects of 4'-demethylnobiletin, a metabolite of nobiletin, on 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced inflammation in mouse ears. J Agric Food Chem 2015;63:10921–10927.
   PubMed Web of Science ®Google Scholar
• Ghosh S, Karin M. Missing pieces in the NF-kappaB puzzle. Cell 2002;109 Suppl:S81–S96.
   PubMed Web of Science ®Google Scholar
• Hsu H, Xiong J, Goeddel DV. The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell 1995;81:495–504.
   PubMed Web of Science ®Google Scholar
• Aggarwal BB. Nuclear factor-kappaB: the enemy within. Cancer Cell 2004;6:203–208.
   PubMed Web of Science ®Google Scholar
• Baeuerle PA, Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 1994;12:141–179.
   PubMed Web of Science ®Google Scholar
• Zhang G, Ghosh S. Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity. J Clin Invest 2001;107:13–19.
   PubMed Web of Science ®Google Scholar
• Gloire G, Legrand-Poels S, Piette J. NF-kappaB activation by reactive oxygen species: fifteen years later. Biochem Pharmacol 2006;72:1493–1505.
   PubMed Web of Science ®Google Scholar
• Ma J, Liang H, Jin HR, et al. Yangonin blocks tumor necrosis factor-α-induced nuclear factor-κB-dependent transcription by inhibiting the transactivation potential of the RelA/p65 subunit. J Pharmacol Sci 2012;118:447–454.
   PubMed Web of Science ®Google Scholar
• Nakano H, Shindo M, Sakon S, et al. Differential regulation of IkappaB kinase alpha and beta by two upstream kinases, NF-kappaB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1. Proc Natl Acad Sci USA 1998;95:3537–3542.
   PubMed Web of Science ®Google Scholar
• Meshnick SR. Artemisinin: mechanisms of action, resistance and toxicity. IntJ Parasitol 2002;32:1655–1660.
   PubMed Web of Science ®Google Scholar
• Tambo E, Khater EI, Chen JH, et al. Nobel prize for the artemisinin and ivermectin discoveries: a great boost towards elimination of the global infectious diseases of poverty. Infect Dis Poverty 2015;4:58.
   PubMed Web of Science ®Google Scholar
• Napetschnig J, Wu H. Molecular basis of NF-kappaB signaling. Annu Rev Biophys 2013;42:443–468.
   PubMed Web of Science ®Google Scholar
• Huxford T, Huang DB, Malek S, et al. The crystal structure of the IkappaBalpha/NF-kappaB complex reveals mechanisms of NF-kappaB inactivation. Cell 1998;95:759–770.
   PubMed Web of Science ®Google Scholar
• Jacobs MD, Harrison SC. Structure of an IkappaBalpha/NF-kappaB complex. Cell 1998;95:749–758.
   PubMed Web of Science ®Google Scholar
• Viatour P, Merville MP, Bours V, et al. Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends Biochem Sci 2005;30:43–52.
   PubMed Web of Science ®Google Scholar
• Aggarwal BB. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 2003;3:745–756.
   PubMed Web of Science ®Google Scholar
• Hsu H, Huang J, Shu HB, et al. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 1996;4:387–396.
   PubMed Web of Science ®Google Scholar
• Stanger BZ, Leder P, Lee TH, et al. RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell 1995;81:513–523.
   PubMed Web of Science ®Google Scholar
• Chinnaiyan AM, O'Rourke K, Tewari M, et al. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 1995;81:505–512.
   PubMed Web of Science ®Google Scholar
• Hoesel B, Schmid JA. The complexity of NF-κB signaling in inflammation and cancer. Mol Cancer 2013;12:86.
   PubMed Web of Science ®Google Scholar
• Karin M, Greten FR. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 2005;5:749–759.
   PubMed Web of Science ®Google Scholar
• Hirschowitz E, Hidalgo G, Doherty D. Induction of cyclo-oxygenase-2 in non-small cell lung cancer cells by infection with DeltaE1, DeltaE3 recombinant adenovirus vectors. Gene Therapy 2002;9:81–84.
   PubMed Web of Science ®Google Scholar
• Kipanyula MJ, Seke Etet PF, Vecchio L, et al. Signaling pathways bridging microbial-triggered inflammation and cancer. Cell Signal 2013;25:403–416.
   PubMed Web of Science ®Google Scholar
• Gantke T, Sriskantharajah S, Sadowski M, et al. IκB kinase regulation of the TPL-2/ERK MAPK pathway. Immunol Rev 2012;246:168–182.
   PubMed Web of Science ®Google Scholar
• Kyriakis JM, Avruch J. Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update. Physiol Rev 2012;92:689–737.
   PubMed Web of Science ®Google Scholar